Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 12, 2026 16:05 ET | Source: ImmuCell Corporation

ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results

PORTLAND, Maine, Oct. 12, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets...
October 12, 2026 16:05 ET | Source: Nurix Therapeutics, Inc.

Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Dosed first patient in registrational Phase 3 DAYBreak CLL-306 trial comparing bexobrutideg with pirtobrutinib in relapsed/refractory CLL/SLL Advanced bexobrutideg combination strategy with...
October 12, 2026 16:05 ET | Source: Ernexa Therapeutics Inc.

Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series

Live video webcast with Sanjeev Luther, President and Chief Executive Officer; Dr. Christopher Rohde, developer of the technology underlying Ernexa’s platform and member of Ernexa’s Scientific...
October 12, 2026 16:05 ET | Source: LifeVantage Corporation

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SALT LAKE CITY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to...
October 12, 2026 16:05 ET | Source: Howard Hughes Holdings Inc.

Howard Hughes Holdings Inc. Announces Dates and Times for 2026 Third Quarter Earnings Release and Conference Call

THE WOODLANDS, Texas, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Howard Hughes Holdings Inc. (NYSE: HHH) (“the Company” or “Howard Hughes”) announced today that the Company will release 2026 third quarter...
October 12, 2026 16:05 ET | Source: Oncolytics Biotech, Inc.

Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update

Oncolytics extends pelareorep patent protection into the late 2040s while planning new IP for next-generation pelareorep.
October 12, 2026 16:03 ET | Source: The Rosen Law Firm PA

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Webull Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BULL

NEW YORK, Oct. 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Webull...
October 12, 2026 16:03 ET | Source: Upwork Inc.

Upwork to Report Third Quarter Financial Results on November 2, 2026

PALO ALTO, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced that it will report its financial results for the...
October 12, 2026 16:01 ET | Source: The Tour of Chongming Island

Elite-Radfahrerinnen bereiten sich auf die dreietappige „Tour of Chongming Island“ vor

SHANGHAI, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Die „Tour of Chongming Island“, ein hochkarätiges Etappenrennen im Straßenradsport für Elite-Frauen, findet vom 9. bis zum 11. Oktober statt und bringt...
October 12, 2026 16:01 ET | Source: The Tour of Chongming Island

Cicliste d’élite si preparano per il giro di tre tappe dell’isola di Chongming

SHANGHAI, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Il tour dell’isola di Chongming, una delle principali gare di ciclismo femminile élite su strada a tappe, si svolge dal 9 all’11 ottobre, riunendo...